tiprankstipranks
Circio Holding ASA Leads in RNA Biotech Innovations
Company Announcements

Circio Holding ASA Leads in RNA Biotech Innovations

Targovax ASA (GB:0RIS) has released an update.

Pick the best stocks and maximize your portfolio:

Circio Holding ASA’s CEO and CSO are set to present at key RNA conferences in Frankfurt and San Diego, spotlighting their pioneering circular RNA technology and its potential in gene therapy. Their participation alongside industry giants such as Moderna and Biontech emphasizes Circio’s role as a leader in this innovative field. The company is also advancing a cancer vaccine, TG01, in various clinical trials, supported by prestigious research grants.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskCircio CTO Exercises Warrants Amidst RNA Tech Advances
TipRanks European Auto-Generated NewsdeskCircio Holding ASA Expands Share Capital Amid Therapeutics Focus
TipRanks European Auto-Generated NewsdeskCircio CEO Exercises Warrants Amid Biotech Advancements
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App